PureTech Health plc (NASDAQ:PRTC) stock is up on Monday, after the company announced results from ELEVATE IPF Phase 2b trial of deupirfenidone (LYT-100) for idiopathic pulmonary fibrosis (IPF). The ...
ICC BOE incumbent Bruce Naramore, candidate Cheryl Francouer Trefzger, ICC student moderator Matthew Farragher,ICC student moderator Akilah Drummond, candidate Barbara-Anne Johnson-Heimroth, candidate ...
On Tuesday, Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released topline results from its Phase 2 FIGHT DMD trial. The study evaluated ifetroban, a novel oral therapy for Duchenne muscular dystrophy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback